FF Pharma
FF Pharma, a biopharmaceutical company, develops anti-CD40 monoclonal antibody therapy for the treatment of chronic inflammatory diseases.
Funding reportedLast round: Series A
What company datasets say FF Pharma raised
Funding, as reported
Reported in all4Min the source's currency
Rounds1
Last roundSeries A
Last round dateJan 2013
Investors listed3
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put FF Pharma in front of investors. Or tell us what we have wrong.